PI
AGN

Parkside Investments’s Allergan plc AGN Stock Holding History

Parkside Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,070
Closed -$2.21M – 121
2019
Q1 		$2.21M Buy
15,070
+1,480
+11% +$215K 0.6% 59
2018
Q4 		$1.82M Sell
13,590
-2,220
-14% -$364K 0.79% 47
2018
Q3 		$3.01M Sell
15,810
-35
-0.2% -$6.43K 1.42% 18
2018
Q2 		$2.83M Buy
15,845
+275
+2% +$44.1K 1.39% 20
2018
Q1 		$2.62M Buy
15,570
+1,190
+8% +$200K 1.36% 21
2017
Q4 		$2.35M Sell
14,380
-1,790
-11% -$321K 1.15% 35
2017
Q3 		$3.31M Buy
16,170
+1,015
+7% +$236K 1.91% 21
2017
Q2 		$3.68M Buy
15,155
+720
+5% +$169K 2.29% 13
2017
Q1 		$3.45M Buy
+14,435
New +$3.36M 2.43% 17

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parkside Investments's AGN Position: Q2 2019 in Review

Parkside Investments sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 15,070 shares — an estimated $2.21M sold.

Parkside Investments first reported a position in AGN in Q1 2017 and held it in 9 quarters. The position peaked at $3.68M in Q2 2017. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Parkside Investments reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Parkside Investments sold 15,070 Allergan plc shares in Q2 2019, an estimated $2.21M.
  • Parkside Investments first reported a position in Allergan plc in Q1 2017 and held it in 9 quarters.
  • Parkside Investments's Allergan plc position peaked at $3.68M in Q2 2017.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Parkside Investments's 13F filing for Q2 2019, filed 2 Aug 2019.